Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Besifloxacin Hydrochloride (BOL-303224-A) 是一种氟喹诺酮类抗生素。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 263 | 现货 | ||
10 mg | ¥ 383 | 现货 | ||
25 mg | ¥ 825 | 现货 | ||
50 mg | ¥ 1,520 | 现货 | ||
100 mg | ¥ 2,970 | 现货 | ||
200 mg | ¥ 4,450 | 现货 | ||
500 mg | ¥ 6,950 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 339 | 现货 |
产品描述 | Besifloxacin Hydrochloride (BOL-303224-A) is a fourth-generation fluoroquinolone antibiotic. |
体外活性 | Besifloxacin has effectively bactericidal activity against prevalent and drug-resistant pathogens. Besifloxacin is the most potent agent tested against gram-positive pathogens and anaerobes and is generally equivalent to comparator fluoroquinolones in activity against most gram-negative pathogens. Besifloxacin demonstrates potent, broad-spectrum activity, which is particularly notable against gram-positive and gram-negative isolates that are resistant to other fluoroquinolones and classes of antibacterial agents. |
激酶实验 | 20 ng of purified human DDK, together with increasing concentrations of each DDK inhibitor is pre-incubated for 5 min. Then 10 μCi (γ)-32P ATP and 1.5 μM cold ATP are added in a buffer containing 50 mM Tris-HCl (pH 7.5), 10 mM MgCl2, and 1 mM DTT and incubated for 30 min at 30°C. The proteins are denatured in 1X Laemmli buffer at 100°C followed by SDS-PAGE and autoradiography on HyBlot CL film. DDK kinase activity is indicated by Auto-phosphorylation of DDK. 32P-labeled bands are quantified using ImageJ and the IC50 values are calculated using GraphPad. |
别名 | BOL-303224-A, Besivance hydrochloride, Besifloxacin HCl, 盐酸贝西沙星 |
分子量 | 430.3 |
分子式 | C19H21ClFN3O3·HCl |
CAS No. | 405165-61-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 11 mg/mL (25.56 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.324 mL | 11.6198 mL | 23.2396 mL | 58.099 mL |
5 mM | 0.4648 mL | 2.324 mL | 4.6479 mL | 11.6198 mL | |
10 mM | 0.2324 mL | 1.162 mL | 2.324 mL | 5.8099 mL | |
20 mM | 0.1162 mL | 0.581 mL | 1.162 mL | 2.905 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Besifloxacin Hydrochloride 405165-61-9 Microbiology/Virology Antibiotic Antibacterial BOL-303224-A Besivance hydrochloride Besivance Hydrochloride Besifloxacin HCl Besifloxacin Bacterial Inhibitor inhibit 盐酸贝西沙星 inhibitor